Lack of pharmacokinetic interaction between retigabine and phenobarbitone at steady-state in healthy subjects

AIMS: To evaluate potential pharmacokinetic interactions between phenobarbitone and retigabine, a new antiepileptic drug. METHODS: Fifteen healthy men received 200 mg of retigabine on day 1. On days 4–32, phenobarbitone 90 mg was administered at 22.00 h. On days 26–32, increasing doses of retigabine...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ferron, Geraldine M, Patat, Alain, Parks, Virginia, Rolan, Paul, Troy, Steven M
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Science Inc 2003
Ämnen:
Pharmacokinetics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884339/
https://ncbi.nlm.nih.gov/pubmed/12848774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01825.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk